United States · FDA National Drug Code directory
Rivastigmine Tartrate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 55111-353_b6b13871-d413-7582-bd37-090b800d61f0
- Product NDC
- 55111-353
- Form
- CAPSULE
- Composition / generic term
- Rivastigmine Tartrate
- Labeler
- Dr. Reddy's Laboratories Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20110901
- Source listing expiry
- 20261231
Source-listed ingredients
- RIVASTIGMINE TARTRATE — 3 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE (55111-353-01) · 55111-353-01
- 500 CAPSULE in 1 BOTTLE (55111-353-05) · 55111-353-05
- 30 CAPSULE in 1 BOTTLE (55111-353-30) · 55111-353-30
- 60 CAPSULE in 1 BOTTLE (55111-353-60) · 55111-353-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →